1. Home
  2. BLZE vs STRO Comparison

BLZE vs STRO Comparison

Compare BLZE & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

N/A

Current Price

$7.27

Market Cap

489.2M

Sector

Technology

ML Signal

N/A

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

N/A

Current Price

$8.76

Market Cap

159.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLZE
STRO
Founded
2007
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
489.2M
159.5M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
BLZE
STRO
Price
$7.27
$8.76
Analyst Decision
Buy
Strong Buy
Analyst Count
7
14
Target Price
$21.50
★ $44.69
AVG Volume (30 Days)
★ 2.6M
291.0K
Earning Date
11-02-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 58.56
N/A
EPS
★ N/A
N/A
Revenue
★ $145,835,000.00
$38,419,000.00
Revenue This Year
$22.07
N/A
Revenue Next Year
$25.20
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 14.27
N/A
52 Week Low
$3.26
$0.72
52 Week High
$23.99
$43.85

Technical Indicators

Market Signals
Indicator
BLZE
STRO
Relative Strength Index (RSI) 36.49 35.40
Support Level $6.82 $8.11
Resistance Level $9.17 $10.77
Average True Range (ATR) 0.74 0.85
MACD 0.06 0.14
Stochastic Oscillator 17.21 17.01

Price Performance

Historical Comparison
BLZE
STRO

About BLZE Backblaze Inc.

Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: